NO168770C - Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivaterInfo
- Publication number
- NO168770C NO168770C NO873091A NO873091A NO168770C NO 168770 C NO168770 C NO 168770C NO 873091 A NO873091 A NO 873091A NO 873091 A NO873091 A NO 873091A NO 168770 C NO168770 C NO 168770C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- analogy procedure
- benzimidazold
- derivatives
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17375986 | 1986-07-25 | ||
JP62171139A JPH0784462B2 (ja) | 1986-07-25 | 1987-07-10 | ベンゾイミダゾ−ル誘導体 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO873091D0 NO873091D0 (no) | 1987-07-23 |
NO873091L NO873091L (no) | 1988-01-26 |
NO168770B NO168770B (no) | 1991-12-23 |
NO168770C true NO168770C (no) | 1992-04-01 |
Family
ID=26493951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO873091A NO168770C (no) | 1986-07-25 | 1987-07-23 | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater |
Country Status (10)
Country | Link |
---|---|
US (1) | US4886803A (de) |
EP (1) | EP0254322B1 (de) |
JP (1) | JPH0784462B2 (de) |
KR (1) | KR960011388B1 (de) |
AU (1) | AU597696B2 (de) |
CA (1) | CA1305481C (de) |
DE (1) | DE3781845T2 (de) |
ES (1) | ES2044878T3 (de) |
FI (1) | FI91152C (de) |
NO (1) | NO168770C (de) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4966908A (en) * | 1988-03-21 | 1990-10-30 | Ciba-Geigy Corporation | Isonicotinic acid amides for protecting plants against disease |
US5089592A (en) * | 1988-06-09 | 1992-02-18 | The Dow Chemical Company | Biscyclobutarene monomer comprising two cyclobutarene moieties bridged by a divalent radical comprising at least one benzothiazole or benzimidazole linkage |
IT1251144B (it) * | 1991-07-30 | 1995-05-04 | Boehringer Ingelheim Italia | Derivati del benzimidazolone |
DE69311278T2 (de) * | 1992-12-16 | 1997-10-30 | Takeda Chemical Industries Ltd | Stabile pharmazeutische Zubereitung mit Fumagillolderivaten |
US5637724A (en) * | 1995-06-05 | 1997-06-10 | Neurogen Corporation | Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands |
US5637725A (en) * | 1995-06-05 | 1997-06-10 | Neurogen Corporation | Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands |
TW381092B (en) * | 1995-07-07 | 2000-02-01 | Otsuka Pharma Co Ltd | Novel benzimidazole derivatives for use in treating arteriosclerotic diseases |
JP2003522760A (ja) * | 2000-02-09 | 2003-07-29 | ザ プロクター アンド ギャンブル カンパニー | 2−フェニルカルバモイル−ベンジミダゾール類 |
US7183410B2 (en) * | 2001-08-02 | 2007-02-27 | Bidachem S.P.A. | Stable polymorph of flibanserin |
US20030060475A1 (en) * | 2001-08-10 | 2003-03-27 | Boehringer Ingelheim Pharma Kg | Method of using flibanserin for neuroprotection |
UA78974C2 (en) * | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
FR2833494B1 (fr) * | 2001-12-19 | 2006-12-15 | Univ Nantes | Utilisation de composes de la famille des benzamides comme agent immunosuppresseur |
JP2005289816A (ja) * | 2002-05-14 | 2005-10-20 | Banyu Pharmaceut Co Ltd | ベンズイミダゾール誘導体 |
CA2503844A1 (en) * | 2002-10-30 | 2004-05-21 | Merck & Co., Inc. | Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
EP1479676A1 (de) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Benzimidazolderivate als Faktor Xa-Inhibitoren |
US7741341B2 (en) | 2003-05-19 | 2010-06-22 | Sanofi-Aventis Deutschland Gmbh | Benzimidazole-derivatives as factor Xa inhibitors |
US20050239798A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for the treatment of premenstrual and other female sexual disorders |
KR20070014184A (ko) * | 2004-04-22 | 2007-01-31 | 베링거 인겔하임 인터내셔날 게엠베하 | 성기능 장애 치료용 신규 약제학적 조성물 ⅱ |
AU2005324492B2 (en) | 2004-04-23 | 2012-06-07 | Paratek Pharmaceuticals, Inc. | Transcription factor modulating compounds and methods of use thereof |
US20060025420A1 (en) * | 2004-07-30 | 2006-02-02 | Boehringer Ingelheimn International GmbH | Pharmaceutical compositions for the treatment of female sexual disorders |
JP2008511569A (ja) * | 2004-09-03 | 2008-04-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 注意欠如活動過多障害の治療方法 |
WO2006096439A2 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases |
JP2008531714A (ja) * | 2005-03-04 | 2008-08-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 不安障害の治療用及び/又は予防用の医薬組成物 |
WO2006096435A1 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of depression |
WO2006119884A2 (en) * | 2005-05-06 | 2006-11-16 | Boehringer Ingelheim International Gmbh | Method for the treatment of drug abuse with flibanserin |
EP1888070A1 (de) * | 2005-05-19 | 2008-02-20 | Boehringer Ingelheim International GmbH | Verfahren zur behandlung krankheitsbedingter sexueller störungen |
EP1888071A1 (de) * | 2005-05-19 | 2008-02-20 | Boehringer Ingelheim International GmbH | Verfahren zur behandlung arzneimittelinduzierter sexueller störungen |
US8227476B2 (en) | 2005-08-03 | 2012-07-24 | Sprout Pharmaceuticals, Inc. | Use of flibanserin in the treatment of obesity |
KR101289995B1 (ko) | 2005-09-27 | 2013-07-26 | 시오노기 앤드 컴파니, 리미티드 | Pgd2 수용체 길항제 활성을 갖는 설폰아마이드 유도체 |
JP2009513604A (ja) * | 2005-10-29 | 2009-04-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体 |
US20070123540A1 (en) * | 2005-10-29 | 2007-05-31 | Angelo Ceci | Sexual desire enhancing medicaments comprising benzimidazolone derivatives |
US20070105869A1 (en) * | 2005-11-08 | 2007-05-10 | Stephane Pollentier | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders |
WO2007128802A2 (en) * | 2006-05-09 | 2007-11-15 | Boehringer Ingelheim International Gmbh | Use of flibanserin for the treatment of post-menopausal sexual desire disorders |
WO2008000760A1 (en) | 2006-06-30 | 2008-01-03 | Boehringer Ingelheim International Gmbh | Flibanserin for the treatment of urinary incontinence and related diseases |
US20090318469A1 (en) * | 2006-07-14 | 2009-12-24 | Boehringer Ingelheim International Gmbh | Use of Flibanserin for the Treatment of Sexual Disorders in Females |
KR20090042967A (ko) * | 2006-08-14 | 2009-05-04 | 베링거 인겔하임 인터내셔날 게엠베하 | 플리반세린 제형 및 이의 제조방법 |
CL2007002214A1 (es) * | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp |
AR062321A1 (es) * | 2006-08-25 | 2008-10-29 | Boehringer Ingelheim Int | Sistema de liberacion controlada y metodo para fabricarlo |
ES2627221T3 (es) | 2006-12-28 | 2017-07-27 | Rigel Pharmaceuticals, Inc. | Compuestos de heterocicloalquiloxibenzamida N-sustituidos y métodos de uso |
PE20091188A1 (es) | 2007-09-12 | 2009-08-31 | Boehringer Ingelheim Int | Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen |
BR112012008147A2 (pt) * | 2009-09-04 | 2016-03-01 | Novartis Ag | compostos heteroarílicos como inibidores da quinase |
US8518948B2 (en) | 2010-03-10 | 2013-08-27 | Ingenium Pharmaceuticals Gmbh | Inhibitors of protein kinases |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4634704A (en) * | 1983-10-06 | 1987-01-06 | Janssen Pharmaceutica, N.V. | Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines |
-
1987
- 1987-07-10 JP JP62171139A patent/JPH0784462B2/ja not_active Expired - Fee Related
- 1987-07-15 US US07/073,738 patent/US4886803A/en not_active Expired - Lifetime
- 1987-07-16 CA CA000542315A patent/CA1305481C/en not_active Expired - Fee Related
- 1987-07-21 AU AU75965/87A patent/AU597696B2/en not_active Ceased
- 1987-07-21 FI FI873205A patent/FI91152C/fi not_active IP Right Cessation
- 1987-07-23 NO NO873091A patent/NO168770C/no unknown
- 1987-07-24 ES ES87110741T patent/ES2044878T3/es not_active Expired - Lifetime
- 1987-07-24 EP EP87110741A patent/EP0254322B1/de not_active Expired - Lifetime
- 1987-07-24 DE DE8787110741T patent/DE3781845T2/de not_active Expired - Fee Related
- 1987-07-25 KR KR1019870008108A patent/KR960011388B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO873091L (no) | 1988-01-26 |
JPS63146871A (ja) | 1988-06-18 |
DE3781845T2 (de) | 1993-02-18 |
KR880001611A (ko) | 1988-04-25 |
JPH0784462B2 (ja) | 1995-09-13 |
FI873205A (fi) | 1988-01-26 |
ES2044878T3 (es) | 1994-01-16 |
NO168770B (no) | 1991-12-23 |
AU597696B2 (en) | 1990-06-07 |
FI91152B (fi) | 1994-02-15 |
FI873205A0 (fi) | 1987-07-21 |
EP0254322B1 (de) | 1992-09-23 |
NO873091D0 (no) | 1987-07-23 |
DE3781845D1 (de) | 1992-10-29 |
KR960011388B1 (ko) | 1996-08-22 |
FI91152C (fi) | 1994-05-25 |
US4886803A (en) | 1989-12-12 |
EP0254322A1 (de) | 1988-01-27 |
CA1305481C (en) | 1992-07-21 |
AU7596587A (en) | 1988-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO168770C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
NO170629C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater | |
NO172801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater | |
NO871266D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
NO163406C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater. | |
NO168174C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolforbindelser | |
NO862477D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater. | |
NO874032D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
NO167026C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
NO167916C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater | |
NO168355C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
NO169438C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser | |
NO168299C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater | |
NO170976C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylbuten-syrederivater | |
NO172539C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser | |
NO169069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater | |
NO173185C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoxalinforbindelser | |
NO170582C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser | |
NO173061C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner | |
NO169007C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater | |
NO172802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyraner | |
NO169648C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater | |
NO164895C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
NO168103C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aralkylimidazolderivater |